| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/05/2004 | US20040023278 Sialoadhesin family member-2 (SAF-2) |
| 02/05/2004 | US20040023277 Using trinucleotide sequence duplication (CAG) present in gene coding calcium channel protein to diagnose nervous system and psychological disoders |
| 02/05/2004 | US20040023271 Using oligonucleotide sequences and strand displacement amplification to determine the concentration of preferential DNA sequences in sample |
| 02/05/2004 | US20040023270 Novel plant agglutinin gene |
| 02/05/2004 | US20040023269 Oligonucleotide sequences for hybridization, detection and identification of alleles |
| 02/05/2004 | US20040023267 Comprises nucleotide sequences coding cancer associated proteins (CAP) for diagnosis, prevention and treatment of tumors |
| 02/05/2004 | US20040023262 Targeted manipulation of genes in plants |
| 02/05/2004 | US20040023260 29 human secreted proteins |
| 02/05/2004 | US20040023258 Method and system or detecting nucleic acids |
| 02/05/2004 | US20040023257 Comprises nucleotide sequences coding proteolytic enzymes for increasing flavor in food, promoting microbiocidal activity, modifying and deprotecting chemical intermediates, synthesis and hydrolysis of cephalosporins |
| 02/05/2004 | US20040023256 Translation profiling |
| 02/05/2004 | US20040023255 Motor proteins and methods for their use |
| 02/05/2004 | US20040023249 Multicompartment apparatus for detection, quantification and sequence determination of one or more molecular structures; high throughput assay |
| 02/05/2004 | US20040023246 Method for detection of inflammatory processes |
| 02/05/2004 | US20040023240 Combinatorial production of nucleotide and nucleoside(xitp)analogues |
| 02/05/2004 | US20040023239 Using transfer rna splicing endonuclease and oligonucleotide probes to preferentially locate, hybridize and split target messenger rna sequences comprising bulge-helix-bulge conformations |
| 02/05/2004 | US20040023232 Primer for diagnosis of one or more kinds of cancer |
| 02/05/2004 | US20040023231 Computational identification of consensus nucleotide sequences common to mRNAs that contain adenylate uridylate-rich elements (AREs), use of these sequences to search gene databases and to design primers, selectively amplify and clone the mRNAs |
| 02/05/2004 | US20040023230 Chemically modified genomic sequences of genes associated with pharmacogenomics, oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of these genes which are directed against the sequence |
| 02/05/2004 | US20040023213 Domain specific gene evolution |
| 02/05/2004 | US20040023207 Assays for screening compounds based on their effectiveness in modulating such microcompetition; effective compounds can be used in treatment of these chronic diseases |
| 02/05/2004 | US20040023205 Method of recovering a nucleic acid encoding a proteinaceous binding domain which binds a target material |
| 02/05/2004 | US20040023204 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 02/05/2004 | US20040022881 Antioxidant food and beverage supplements |
| 02/05/2004 | US20040022812 Herpes viruses for immune modulation |
| 02/05/2004 | US20040022809 Cold-adapted equine influenza viruses |
| 02/05/2004 | US20040022803 Base205 polypeptides and polynucleotides therefor |
| 02/05/2004 | US20040022801 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/05/2004 | US20040022799 Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 02/05/2004 | US20040022785 Expression of herstatin, an alternative HER-2/neu product, in cells that express either p185HER-2 or the EGF receptor inhibits receptor activity and cell growth |
| 02/05/2004 | US20040022782 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 02/05/2004 | US20040022781 Proteins and nucleic acids encoding same |
| 02/05/2004 | US20040022772 Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth |
| 02/05/2004 | US20040022769 To induce killing of tumor cells and concomitantly mobilize differentiate, activate and attract dendritic cells through the expression of cytokines and dendritic cell chemoattractants |
| 02/05/2004 | US20040022767 Novel cytokine designated elk ligand |
| 02/05/2004 | US20040022766 Administering by subretinal injection an effective amount of recombinant adeno-associated virus carrying a nucleic acid sequence encoding normal gene under the control of promoter sequence which expresses the product of gene in ocular cells |
| 02/05/2004 | US20040022765 For cancer therapy |
| 02/05/2004 | US20040022764 Inhibition of microcompetition with a foreign polynucleotide as treatment of chronic disease |
| 02/05/2004 | US20040022763 Human recombinant beta-interferon with improved solubility |
| 02/05/2004 | US20040022727 For therapy of proliferative diseases |
| 02/05/2004 | US20040021949 Apparatus and method for fabricating, sorting, and integrating materials with holographic optical traps |
| 02/05/2004 | DE10333144A1 Production of citric acid, useful as e.g. flavoring in foods and pharmaceuticals, by growing Yarrowia lipolytica that has been modified to increase isocitrate lyase activity |
| 02/05/2004 | DE10233327A1 Verfahren zum Erreichen einer Pathogenresistenz in Pflanzen A method for obtaining a pathogen resistance in plants |
| 02/05/2004 | DE10233064A1 gM-negative EHV-Mutanten ohne heterologe Elemente gM-negative EHV mutants without heterologous elements |
| 02/05/2004 | DE10232930A1 Verfahren zur fermentativen Herstellung von Aminosäuren und Aminosäure-Derivaten der Phosphoglycerat-Familie A process for the fermentative production of amino acids and amino acid derivatives of the phosphoglycerate family |
| 02/05/2004 | DE10232483A1 Transgene Expressionskonstrukte und Verfahren zum Erhöhen des Vitamin E-Gehaltes in pflanzlichen Organismen The transgenic expression constructs and methods for increasing the vitamin E content in plant organisms |
| 02/05/2004 | DE10232196A1 In vitro or in vivo site-specific DNA recombination, useful e.g. for gene inactivation, using Cre recombinase that lacks heterologous protein-transduction domain |
| 02/05/2004 | DE10231297A1 Nukleotidsequenzen coryneformer Bakterien codierend für an der Biosynthese von L-Serin beteiligte Proteine sowie Verfahren zur Herstellung von L-Serin Nucleotide sequences coding for coryneform bacteria involved in the biosynthesis of L-serine proteins and processes for the production of L-serine |
| 02/05/2004 | CA2727782A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/05/2004 | CA2531779A1 Multi-reporter gene model for toxicological screening |
| 02/05/2004 | CA2518732A1 Assays and methods based on microcompetition with a foreign polynucleotide |
| 02/05/2004 | CA2518588A1 Hybrid dna polymerase proteins having increased polymerase to exonuclease activity |
| 02/05/2004 | CA2494793A1 Novel serine protease |
| 02/05/2004 | CA2494485A1 Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies |
| 02/05/2004 | CA2494262A1 Polymorphisms for predicting disease and treatment outcome |
| 02/05/2004 | CA2493952A1 Virus induced gene silencing in plants |
| 02/05/2004 | CA2493949A1 Modified small interfering rna molecules and methods of use |
| 02/05/2004 | CA2493638A1 New mutant strains of pseudomonas fluorescens and variants thereof, methods for their production, and uses thereof in alginate production |
| 02/05/2004 | CA2493613A1 Method for analyzing readings of nucleic acid assays |
| 02/05/2004 | CA2493590A1 Auto-stimulating cells and method for making and using the same |
| 02/05/2004 | CA2493306A1 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 02/05/2004 | CA2493264A1 New method for analyzing nucleic acid and use thereof for evaluating the degree of mrna editing of the serotonin 5-ht2c receptor |
| 02/05/2004 | CA2493187A1 Nuclear transfer embryo formation method |
| 02/05/2004 | CA2492933A1 Method and device for screening molecules in cells |
| 02/05/2004 | CA2492501A1 Method for enhancing the nutritive value of plant extract |
| 02/05/2004 | CA2492500A1 Method for enhancing yield of recombinant protein production from plants |
| 02/05/2004 | CA2492463A1 Regulated aptamer therapeutics |
| 02/05/2004 | CA2492450A1 Microfluidic device including purification column with excess diluent, and method |
| 02/05/2004 | CA2492447A1 Taci antibodies and uses thereof |
| 02/05/2004 | CA2492444A1 Modified adamts4 molecules and method of use thereof |
| 02/05/2004 | CA2492333A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/05/2004 | CA2492332A1 Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin b12 biosynthesis |
| 02/05/2004 | CA2486283A1 Methods for fragmentation, labeling and immobilization of nucleic acids |
| 02/05/2004 | CA2484941A1 Antigens encoded by alternative reading frame from pathogenic viruses |
| 02/04/2004 | EP1386973A1 Method of estimating diplotype from genotype of individual |
| 02/04/2004 | EP1386970A1 Combined utilization of genes in the biosynthetic pathway of caffeine |
| 02/04/2004 | EP1386968A1 Gene expression controlling unit and utilization thereof |
| 02/04/2004 | EP1386967A2 DNA Encoding Mammalian phosphodiesterases |
| 02/04/2004 | EP1386966A1 Method for the expression of unknown environmental DNA into adapted host cells |
| 02/04/2004 | EP1386961A2 Modified reductase and its gene and use thereof |
| 02/04/2004 | EP1386933A1 Cytokine antagonists and agonists |
| 02/04/2004 | EP1386932A1 Improved humanized immunoglobulins |
| 02/04/2004 | EP1386931A1 Human neurotrimin homologue |
| 02/04/2004 | EP1386930A1 Derivatives of exendin |
| 02/04/2004 | EP1386928A1 A frog skin antibacterial peptide derivative |
| 02/04/2004 | EP1386617A1 Method for the in vitro diagnosis of type II porcine circovirus infection and diagnostic reagents |
| 02/04/2004 | EP1386616A1 Antibordetella vaccine |
| 02/04/2004 | EP1386615A1 EG-VEGF/Prokineticin 2 receptor antagonists |
| 02/04/2004 | EP1386169A1 Three-dimensional microfluidics incorporating passive fluid control structures |
| 02/04/2004 | EP1386163A2 Isolated ductal fluid sample |
| 02/04/2004 | EP1386162A2 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 02/04/2004 | EP1386155A2 Therapeutic and diagnostic uses of antibody specificity profiles |
| 02/04/2004 | EP1386154A1 Automated methods of detecting receptor activity |
| 02/04/2004 | EP1386152A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes |
| 02/04/2004 | EP1386150A1 Insect ammunition vectors and methods of use to identify pesticide targets |
| 02/04/2004 | EP1386009A2 Design of artificial genes for use as controls in gene expression analysis systems |
| 02/04/2004 | EP1386007A2 Skin treatment |
| 02/04/2004 | EP1386006A1 Methods for nucleic acid manipulation |
| 02/04/2004 | EP1386005A1 Methods for high throughput genome analysis using restriction site tagged microarrays |
| 02/04/2004 | EP1386004A2 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies |